Literature DB >> 625570

Impaired renal production of prostaglandin E2: a newly identified lesion in human essential hypertension.

S Y Tan, P Sweet, P J Mulrow.   

Abstract

To test the hypothesis that impaired renal prostaglandin production may accompany the hypertensive state, we have measured urinary PGE2 by radioimmunoassay in 52 normotensive and 50 hypertensive subjects. PGE2 levels were lower in females, and were not affected by Na+ intake or age. Patients with essential hypertension had significantly lower PGE2, particularly those with low-renin hypertension. Forty percent of the hypertensives excreted less than 70 ng/24 hr, values never observed in normotensives except after receiving indomethacin, a well-known prostaglandin synthetase inhibitor. It appears that impaired renal prostaglandin production is commonly encountered in patients with essential hypertension, perhaps contributing to their increased renal resistance. The data further suggest a role for renal prostaglandins in the pathogenesis of low-renin hypertension.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 625570     DOI: 10.1016/s0090-6980(78)80012-4

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  8 in total

1.  Urinary prostaglandins in human neonates: relationship to kidney function and blood pressure.

Authors:  B Scherer; G Friedmann; A Dumbs; K Holzmann; P C Weber
Journal:  Klin Wochenschr       Date:  1980-05-02

Review 2.  Nonsteroidal anti-inflammatory drugs and hypertension. The risks in perspective.

Authors:  P W de Leeuw
Journal:  Drugs       Date:  1996-02       Impact factor: 9.546

3.  Prostaglandin excretion after furosemide in normal and low-renin essential hypertension.

Authors:  B Scherer; H Witzgall; P C Weber
Journal:  Klin Wochenschr       Date:  1984-08-16

4.  Radioimmunoassay measurement of prostaglandins E2 and F2alpha in human urine.

Authors:  G Ciabattoni; F Pugliese; M Spaldi; G A Cinotti; C Patrono
Journal:  J Endocrinol Invest       Date:  1979 Apr-Jun       Impact factor: 4.256

5.  Arachidonic acid metabolites, hypertension and arteriosclerosis.

Authors:  P C Weber; W Siess; B Scherer; E Held; H Witzgall; R Lorenz
Journal:  Klin Wochenschr       Date:  1982-05-17

6.  [Reduced urinary prostaglandin E2-excretion and diminished responsiveness of plasma renin activity in patients with essential hypertension (author's transl)].

Authors:  B Scherer; E Held; H H Lange; P C Weber
Journal:  Klin Wochenschr       Date:  1979-06-01

7.  Sodium chloride as regulator of renal prostaglandin E2 production in patients with essential hypertension.

Authors:  R A Stahl; A J Jonassen; M Paravicini; P Schollmeyer
Journal:  Klin Wochenschr       Date:  1982-06-01

8.  Prostaglandin synthesis and renal function in man.

Authors:  J Haylor
Journal:  J Physiol       Date:  1980-01       Impact factor: 5.182

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.